SCHEMBL16057029

SCHEMBL16057029

Cc1ccccc1-c1ccc(-c2ccnc(OC(=O)O)c2C)cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 2/20 0.40
▸ KDM4C Q9H3R0 2/20 0.40
▸ KDM5B Q9UGL1 2/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ PPARG P37231 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ S1PR1 P21453 2/20 0.36
▸ SLC6A9 P48067 1/20 0.36
▸ PLA2G7 Q13093 1/20 0.35
▸ CTSA P10619 3/20 0.35
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ EDNRB P24530 1/20 0.34
▸ EDNRA P25101 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ NR1H4 Q96RI1 1/20 0.34
▸ SLC2A1 P11166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16057661 0.91 SLC2A1 (0.42) KDM5AKDM4CKDM5BMCL1PPARG
SCHEMBL16056981 0.90 SLC6A7 (0.41) KDM5AKDM4CKDM5BMCL1PPARG
SCHEMBL16056701 0.85 KMO (0.41) KDM5AKDM4CKDM5BCTSASLC2A1
SCHEMBL14975894 0.83 PORCN (0.40) KDM5AKDM4CKDM5BMAPTDHODH
SCHEMBL16058355 0.82 PORCN (0.41) —
SCHEMBL16058727 0.81 PTGS1 (0.41) MAPT
SCHEMBL16058822 0.80 DHODH (0.47) PPARGPPARAMAPTDHODH
SCHEMBL16057040 0.78 RAB9A (0.44) MAPT
SCHEMBL16057423 0.77 CCNC (0.39) —
SCHEMBL16058685 0.77 LMNA (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828338-B2 Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-28 — — US disclosed
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-10 — — US disclosed
WO-2014144836-A2 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS NAAA, FAAH, FAAH2 KDM5A 2208/4885KDM4C 2838/4885KDM5B 2330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback